Literature DB >> 8574958

Liver transplants contribute to their own success.

T E Starzl1, N Murase, A Thomson, A J Demetris.   

Abstract

Mesh：

Year:  1996        PMID： 8574958      PMCID： PMC3005701          DOI： 10.1038/nm0296-163

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  22 in total

Review 1.  Cell migration, chimerism, and graft acceptance.

Authors:  T E Starzl; A J Demetris; N Murase; S Ildstad; C Ricordi; M Trucco
Journal:  Lancet       Date:  1992-06-27       Impact factor: 79.321

2.  FACTORS DETERMINING SHORT- AND LONG-TERM SURVIVAL AFTER ORTHOTOPIC LIVER HOMOTRANSPLANTATION IN THE DOG.

Authors:  T E STARZL; T L MARCHIORO; K A PORTER; P D TAYLOR; T D FARIS; T J HERRMANN; C J HLAD; W R WADDELL
Journal:  Surgery       Date:  1965-07       Impact factor: 3.982

Review 3.  The dendritic cell system and its role in immunogenicity.

Authors:  R M Steinman
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

4.  Liver-associated macrophage precursor cells proliferate under impairment of regular hemopoiesis.

Authors:  T Decker; M L Lohmann-Matthes; M Baccarini
Journal:  Eur J Immunol       Date:  1988-05       Impact factor: 5.532

5.  Induction of immunological tolerance by porcine liver allografts.

Authors:  R Y Calne; R A Sells; J R Pena; D R Davis; P R Millard; B M Herbertson; R M Binns; D A Davies
Journal:  Nature       Date:  1969-08-02       Impact factor: 49.962

6.  Hemopoietic stem cells in mouse liver.

Authors:  E F Hays; D M Hays; D W Golde
Journal:  Exp Hematol       Date:  1978-01       Impact factor: 3.084

7.  Reversal of transplantation immunity by liver grafting.

Authors:  N Kamada; H S Davies; B Roser
Journal:  Nature       Date:  1981-08-27       Impact factor: 49.962

8.  Possible active enhancement of a human cadaver renal allograft with antilymphocyte serum (ALS) and donor bone marrow: case report of an initial attempt.

Authors:  A P Monaco; A W Clark; M L Wood; A I Sahyoun; S D Codish; R W Brown
Journal:  Surgery       Date:  1976-04       Impact factor: 3.982

9.  Soluble HLA antigens in the circulation of liver graft recipients.

Authors:  H S Davies; S G Pollard; R Y Calne
Journal:  Transplantation       Date:  1989-03       Impact factor: 4.939

10.  Use of a probe to repeat sequence of the Y chromosome for detection of host cells in peripheral blood of bone marrow transplant recipients.

Authors:  D Przepiorka; E D Thomas; D M Durnam; L Fisher
Journal:  Am J Clin Pathol       Date:  1991-02       Impact factor: 2.493
View more
  8 in total

1.  Nonmyeloablative immunosuppressive regimen prolongs In vivo persistence of gene-modified autologous T cells in a nonhuman primate model.

Authors:  C Berger; M L Huang; M Gough; P D Greenberg; S R Riddell; H P Kiem
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

Review 2.  The role of cell migration and microchimerism in the induction of tolerance after solid organ transplantation.

Authors:  R M Jindal; A Sahota
Journal:  Postgrad Med J       Date:  1997-03       Impact factor: 2.401

3.  Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction.

Authors:  S Qian; L Lu; F Fu; Y Li; W Li; T E Starzl; J J Fung; A W Thomson
Journal:  J Immunol       Date:  1997-05-15       Impact factor: 5.422

4.  Human allograft acceptance is associated with immune regulation.

Authors:  A M VanBuskirk; W J Burlingham; E Jankowska-Gan; T Chin; S Kusaka; F Geissler; R P Pelletier; C G Orosz
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

5.  DAP12 deficiency in liver allografts results in enhanced donor DC migration, augmented effector T cell responses and abrogation of transplant tolerance.

Authors:  O Yoshida; S Kimura; L Dou; B M Matta; S Yokota; M A Ross; D A Geller; A W Thomson
Journal:  Am J Transplant       Date:  2014-06-16       Impact factor: 8.086

Review 6.  Chimerism and tolerance in transplantation.

Authors:  Thomas E Starzl
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-19       Impact factor: 11.205

7.  Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity.

Authors:  S Qian; L Lu; F Fu; W Li; F Pan; R J Steptoe; F G Chambers; T E Starzl; J J Fung; A W Thomson
Journal:  Transplantation       Date:  1998-06-27       Impact factor: 4.939

Review 8.  Transplantation tolerance in nonhuman primates and humans.

Authors:  Megan Sykes; Adam D Griesemer
Journal:  Bone Marrow Transplant       Date:  2019-08       Impact factor: 5.483
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.